Cargando…
Drug-induced hepatitis (DIH) after SARS-CoV-2 vaccination
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Masson SAS.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527185/ https://www.ncbi.nlm.nih.gov/pubmed/36195274 http://dx.doi.org/10.1016/j.clinre.2022.102028 |
| _version_ | 1784801029444861952 |
|---|---|
| author | Asgarzdeh, Ali Habibzadeh, Shahram Asghariazar, Vahid Safarzadeh, Elham |
| author_facet | Asgarzdeh, Ali Habibzadeh, Shahram Asghariazar, Vahid Safarzadeh, Elham |
| author_sort | Asgarzdeh, Ali |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9527185 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Published by Elsevier Masson SAS. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95271852022-10-03 Drug-induced hepatitis (DIH) after SARS-CoV-2 vaccination Asgarzdeh, Ali Habibzadeh, Shahram Asghariazar, Vahid Safarzadeh, Elham Clin Res Hepatol Gastroenterol Letter to the Editor Published by Elsevier Masson SAS. 2023-02 2022-10-03 /pmc/articles/PMC9527185/ /pubmed/36195274 http://dx.doi.org/10.1016/j.clinre.2022.102028 Text en © 2022 Published by Elsevier Masson SAS. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Asgarzdeh, Ali Habibzadeh, Shahram Asghariazar, Vahid Safarzadeh, Elham Drug-induced hepatitis (DIH) after SARS-CoV-2 vaccination |
| title | Drug-induced hepatitis (DIH) after SARS-CoV-2 vaccination |
| title_full | Drug-induced hepatitis (DIH) after SARS-CoV-2 vaccination |
| title_fullStr | Drug-induced hepatitis (DIH) after SARS-CoV-2 vaccination |
| title_full_unstemmed | Drug-induced hepatitis (DIH) after SARS-CoV-2 vaccination |
| title_short | Drug-induced hepatitis (DIH) after SARS-CoV-2 vaccination |
| title_sort | drug-induced hepatitis (dih) after sars-cov-2 vaccination |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527185/ https://www.ncbi.nlm.nih.gov/pubmed/36195274 http://dx.doi.org/10.1016/j.clinre.2022.102028 |
| work_keys_str_mv | AT asgarzdehali druginducedhepatitisdihaftersarscov2vaccination AT habibzadehshahram druginducedhepatitisdihaftersarscov2vaccination AT asghariazarvahid druginducedhepatitisdihaftersarscov2vaccination AT safarzadehelham druginducedhepatitisdihaftersarscov2vaccination |